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Abstract  
Mitochondria provide an essential role in the maintenance of cellular homeostasis with 
regard to energy generation, redox signaling, and programmed cell death. Consequently, 
fast adaptation to metabolic changes associated with developmental demands or stress 
induction requires a balanced coordination of mitochondrial biogenesis and removal of 
damaged mitochondria. Impaired mitochondrial maintenance is causally linked to many 
human pathologies and ageing, including diabetes, cancer, and neurodegenerative 
diseases. Thus, it is of fundamental importance to understand cellular surveillance 
mechanisms that support a healthy mitochondrial network. In this review, we discuss the 
role of ubiquitin-dependent protein degradation in mitochondrial functionality.  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
Introduction  
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Mitochondria form an essential compartment important to maintain cellular homeostasis in 
eukaryotic organisms. Besides supplying the cell with ATP, mitochondria play a central role in 
anabolic and catabolic processes as well as in cellular signaling pathways. Damaging agents from 
extrinsic or intrinsic sources contribute to mitochondrial impairment and thus endanger cellular 
health and viability. Mitochondria possess intrinsic mechanisms to either refold or terminally 
degrade non-functional or damaged proteins. Genetic or pharmacological induction of 
mitochondrial stress initiates the expression of mitochondria- and nuclear-encoded genes to 
compensate the toxic effects. Recently, an inter-organellar signaling cascade has been described 
between mitochondria and the nucleus involving the conserved transcription factor ATFS1 [1]. 
This transcriptional communication indicates intricately balanced cellular response mechanisms, 
which evolved to assure mitochondrial integrity. In addition to mitochondriaspecific quality control 
pathways [2], cytosolic protein degradation emerges as a critical factor supporting mitochondrial 
homeostasis (Box 1). Intriguingly, recent studies identified ubiquitinmediated protein degradation 
pathways that keep control over multiple aspects of mitochondrial functionality. Failure of 
mitochondrial surveillance supported by the ubiquitin/proteasomesystem (UPS) and autophagy 
(termed mitophagy) are causally linked to severe neurodegenerative diseases such as 
Parkinson’s, Alzheimer’s, and Huntington’s disease (PD, AD, HD) [3]. Notably, other age-related 
pathologies, including diabetes mellitus and cancer, are also accompanied with functional decline 
of mitochondrial metabolism. In this review we focus on mitochondrial surveillance mechanisms 
provided by cytosolic protein degradation pathways governed by ubiquitin (Figure 1).  
  
Proteasomal degradation ensures a dynamic mitochondrial network  
Mitochondria assemble a highly dynamic and interconnected network that is constantly modified 
by fission and fusion events. The dynamic nature of the mitochondrial network provides an elegant 
mechanism controlling its functionality [4]. Damaged fractions can be segregated by fission events 
that promote the budding of mitochondrial membranes, enabling subsequent degradation of the 
compromised compartments. Alternatively, fusion with the healthy mitochondrial pool can 
complement a mitochondrion’s functional deficiency. Respective regulatory factors determining 
mitochondrial morphology by dynamic fission and fusion have been identified. Dynamin-related 
proteins (Drp1 in mammals, Dmn1 in yeasts) promote mitochondrial fission and catalyze the 
segregation of a continuous mitochondrion into separated functional fragments. In contrast, 
mitofusins (Mfn1 and Mfn2 in mammals, Fzo1 in yeast) promote fusion of individual mitochondria. 
Both fission and fusion events underlie the cellular control by ubiquitin-mediated regulation of 
Drp1/Dnm1 or mitofusins [5] (Figure 1, Table 1).  
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Several E3 ubiquitin ligases have been identified to define the dynamic mitochondrial network 
(Table 1, references therein). On one hand, degradation of fission promoting Drp1/Dnm1 and Fis1 
proteins is supposed to promote fusion and elongation of mitochondria. Conversely, targeted 
degradation of mitofusins facilitates mitochondrial fragmentation (Table 1, references therein). In 
addition to ubiquitin-mediated turnover of mitofusins, non-proteolytic mechanisms have been 
identified, involving ubiquitin-dependent oligomerization and thus activation of mitochondrial 
fusion [6], [7]. Some E3 ligases selectively target several protein substrates, illustrating that the 
regulation of mitochondrial dynamics is finely tuned and multilayered [6,8]. In line with this idea, 
the metabolic or developmental status critically influence the mitochondrial morphology and 
dynamics [9,10]. Remarkably, it remains largely elusive how the activity of particular E3 ligases 
and DUBs is regulated at mitochondria. It will be important to uncover the molecular mechanisms 
that integrate ubiquitylation and deubiquitylation activity into the cellular signalling pathways that 
sense and modify mitochondrial dynamics [9]. Nonetheless, ubiquitinmediated protein 
degradation is vital in controlling the mitochondrial network, which is further modulated by 
deubiquitylating enzymes (DUBs) that regulate fission and fusion events [6], [11]– [13] (Box 1).   
In addition to fission-fusion balance, the dynamics and integrity of the mitochondrial network 
strictly depends on active transport along the microtubule (MT) cytoskeleton, facilitating effective 
distribution and energy supply. Mitochondrial transport is particularly important in neurons to 
coordinate efficient distribution between the cell body and the distal synapse. Miro is a component 
of the protein complex that links mitochondria to MT-associated motor proteins [14]. Intriguingly, 
Miro has been identified as a target of the UPS, regulating mitochondrial transport and axonal 
distribution [15], [16]. Consequently, loss of Miro or the respective E3 ligase Parkin disturb 
mitochondrial transport in neurons as well as mitochondrial distribution in other cell types, affecting 
the morphology and functionality of the mitochondrial network [15], [16].  
  
Protein quality control at mitochondria is executed by MAD  
Besides other regulatory functions, the UPS is fundamental in maintaining cellular protein 
homeostasis (proteostasis) by degradation of aberrant proteins both in the cytosol and the 
nucleus. Ubiquitin-dependent degradation also triggers proteostasis in other cellular 
compartments including endosymbiotic mitochondria and plastids [17]. Recently, a dedicated 
proteolytic machinery has been characterized that catalyzes the degradation of 
mitochondriaassociated proteins by the cytosolic proteasome (mitochondria-associated protein 
degradation, MAD) [18]–[21] (Figure 1). Accumulation of aberrant and damaged proteins inside 
and outside of mitochondria is linked to functional decline, threatening cellular health and viability.  
Accordingly, many human disorders are linked to impaired mitochondrial proteostasis (Table 2).  
5  
  
Proteins localized in the inner- and outer mitochondrial membrane (IMM, OMM), as well as the 
inter-membrane space (IMS) are degraded by the cytosolic UPS [22]–[26] (Figure 1). The exact 
mechanism involving the recognition and presentation of proteins localized in the matrix space, 
IMM, or IMS remains to be discovered. Proteases and membrane translocons inside these 
subcompartments are activated by the mitochondrial unfolded protein response (UPRmit) since 
they play a vital role in proteostasis [27]–[29]. In analogy to UPS-dependent degradation of 
proteins accumulating in the endoplasmic reticulum (ER-associated protein degradation, ERAD), 
MAD is involved in translocation of substrates across/from the OMM to enable transfer to the 
cytosolic proteasome (Figure 1). Similarly to ERAD, the highly conserved ubiquitindirected 
segregase Cdc48/p97/VCP (hereafter named Cdc48/p97) facilitates substrate translocation from 
the OMM [30] [31]. Upon induction of mitochondrial protein stress, the cofactor Vms1 relocalizes 
from the cytosol to mitochondria, which is required for Cdc48/p97 recruitment to the mitochondrial 
membrane [25]. Consistent with the concept of stress-induced mitochondrial degradation, loss of 
Vms1 sensitizes yeast and C. elegans towards stress conditions. In contrast, however, Vms1 is 
dispensable for Cdc48/p97-dependent regulation of mitochondrial morphology in otherwise 
unstressed conditions [32]. Thus, Cdc48/p97 presumably affects multiple aspects of mitochondrial 
function, which might be modulated by Vms1. The observation that Cdc48/p97 and Vms1 are able 
to attenuate cytotoxic aspects of  
Alzheimer’s disease further illustrates the relevance of UPS-mediated mitochondrial proteostasis 
in neurodegeneration [33]. Upon pharmacological uncoupling of proton transport from ATP-
synthesis, several mitochondrial proteins are ubiquitylated [34], [35]. Cdc48/p97dependent 
proteasomal degradation of ubiquitylated mitofusins facilitates mitochondrial fragmentation, which 
in turn promotes the clearance of affected mitochondria by mitophagy [30], [36] (Figure 1). 
Ccd48/p97 thus forms an essential bridge between safeguarding mitochondrial function through 
fission-fusion balance or the terminal removal of damaged mitochondria by autophagy [37].  
  
PINK1/Parkin orchestrates proteasomal degradation and mitophagy   
In contrast to turnover of damaged proteins, complete proteolysis of entire mitochondria is 
mediated via autophagy. Under physiological conditions mitochondrial autophagy (mitophagy) is 
involved in adjusting mitochondrial mass for the metabolic needs of the cell and also removes 
mitochondria during differentiation processes. In most animals, paternal mitochondria are actively 
eliminated through selective mitophagy after fertilization of the oocyte, which ensures maternal 
inheritance of mitochondrial DNA [38], [39]. On the other hand, mitophagy provides an essential 
quality control mechanism in mitochondrial proteostasis maintenance. When mitochondria 
become damaged, they lose their membrane potential and are segregated from the mitochondrial 
network before autophagosomal engulfment and lysosomal degradation (Figure 1). The E3 
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ubiquitin ligase Parkin and the PTEN-induced putative kinase protein 1 (PINK1) cooperate in 
targeting damaged mitochondria for degradation [40]. The Ser/Thr kinase PINK1 phosphorylates 
both Parkin and ubiquitin, which leads to the activation and mitochondrial recruitment of the E3 
ligase [41]–[43]. Moreover, phosphorylated ubiquitin chains on the mitochondria act as Parkin 
receptor and trigger further cycles of Parkin translocation to the damaged organelle [44]. PINK1-
mediated phosphorylation of mitofusin 2 provides an additional  critical step in mitochondrial 
Parkin recruitment [45], suggesting a mutual crosstalk between both protein modification systems 
in mitophagy initiation. Upon stress-induced activation of mitophagy Parkin ubiquitylates several 
mitochondrial substrates [34]. Ubiquitylation of mitochondrial proteins of the IMM, OMM, and IMS 
serves as degradation signal for turnover by the 26S proteasome, however, it also recruits the 
autophagic machinery to specifically recognize and remove dysfunctional mitochondria (Figure 
1). It is likely that Parkin-induced ubiquitylation and proteasomal degradation of several OMM 
proteins precedes the initiation of mitophagy and interfering with proteasomal removal of these 
mitochondrial proteins attenuates autophagosomal degradation of mitochondria [46] [37]. Indeed, 
Parkin-mediated proteasomal turnover of mitofusins is crucial in fission-driven separation of 
damaged mitochondria parts, leading to selective ubiquitylation of dysfunctional mitochondria [36], 
[45].  
Deubiquitylating enzymes (DUBs) oppose the activity of E3 ligases by removing ubiquitin 
molecules attached to substrate proteins (Box 1). So far only few DUBs were functionally linked 
to mitophagy (Table 1). USP8 is involved in promoting Parkin recruitment to the mitochondria 
through direct deubiquitylation of the E3 ligase [47]. USP15 and USP30 inhibit mitophagy by 
deubiquitylating Parkin targets on the mitochondrial surface [13], [48], [49], (Table 1). Interestingly, 
chains of phosphorylated ubiquitin were suggested to be resistant to DUBmediated hydrolysis 
thus amplifying the degradation signal generated by PINK1/Parkin [50].  
The Parkin-generated ubiquitin coat on mitochondria is a major driving force in the recruitment of 
the autophagic membrane around the dysfunctional organelles (Figure 1). Ubiquitin-binding 
autophagy receptors such as p62, optineurin or NBR1 [46], [51]–[53] are recruited to the damaged 
organelle where they simultaneously bind to the ubiquitylated cargo and to the autophagosomal 
membranes. A common element of all autophagy receptor proteins is the LIRmotif that directly 
bind LC3 family proteins on the surface of the growing engulfment membrane, initiating 
autophagic removal of the cargo [54]. After internalization of the mitochondria, autophagosomes 
fuse with the lysosomes and degrade the content of the vesicles by hydrolytic enzymes (Figure 
1).  
PINK1 and Parkin are involved in the recently discovered alternative quality control mechanism 
that uses the vesicular trafficking pathway to remove damaged mitochondrial components. 
Mitochondria-derived vesicles, that contain selectively incorporated mitochondrial proteins directly 
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fuse with late endosomes or multivesicular bodies for subsequent degradation in lysosomes [55]. 
Although PINK1 and Parkin seem to take the lion's share of mitophagy regulation upon excessive 
mitochondria damage [34], recent results suggest the existence of alternative pathways, which 
likely drive physiological levels of mitophagy. Such an alternative mitochondrial clearance 
mechanism is observed during the differentiation of erythrocytes, where the maturation process 
results in autophagic elimination of organelles, including mitochondria [56], [57].   
  
Crosstalk between UPS and mitophagy   
Proteomics studies revealed that Parkin may regulate ubiquitylation of more than 100 
mitochondrial proteins upon mitochondrial depolarization. Various components of the cytoplasmic 
mitochondrial surveillance machinery, including proteasome subunits, Cdc48/p97 and autophagy 
receptors, are also amongst Parkin targets [34]. This suggests the existence of an intricately 
balanced crosstalk between the UPS and autophagy, with PINK1/Parkindependent ubiquitylation 
providing the central node of mitochondrial proteostasis maintenance.  
The most apparent link between the two proteolytic systems is the common use of ubiquitylation 
as degradation signal. Timely coordinated, UPS-dependent degradation of target proteins at 
mitochondria is essential for subsequent initiation of mitophagy. E3 ubiquitin ligases present at 
the mitochondrial surface, such as Parkin, Mulan, MARCH5/MITOL and RNF185 can ubiquitylate 
various targets on the organelle's surface. For instance, muscle-wasting stimuli in skeletal 
muscles induce mitophagy through Mulan-driven ubiquitylation and proteasomal degradation of 
the mitochondrial fusion protein Mfn2 [58], thus preceding autophagic clearance of mitochondria 
(Figure 1). PINK1-dependent regulation of protein turnover provides another example for the 
crosstalk between the UPS and selective autophagy. When PINK1 is targeted to healthy 
mitochondria it is rapidly degraded by the N-end-rule degradation pathway in the cytoplasm, 
thereby limiting Parkin recruitment to the functional organelle [59].  
UPS activity and the MAD pathway are crucial in maintaining mitochondrial homeostasis. 
Proteasome inhibition induces mitochondrial dysfunction accompanied by excessive 
mitochondrial fragmentation [60]–[62]. On the other hand, mitochondrial dysfunction can 
adversely affect the cytoplasmic protein degradation pathways [63], [64]. Signals generated by 
damaged mitochondria can dramatically alter the activity of UPS. Thus, impairment of mitophagy 
and subsequent increase in mitochondrial ROS production or decrease in ATPsupply has severe 
impact on overall fitness of the cell. Our recent work indicates that oxidative stress caused by 
impaired mitochondrial metabolism attenuates protein degradation at the 26S proteasome (Figure 
1). Accordingly, proteolytic defects of the UPS can be observed in human disorders linked to 
pathological mitochondrial metabolism [63]. While turnover of N-end-rule and UFD-model 
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substrates is reduced upon mitochondrial stress, degradation of mitochondrial proteins via the 
MAD pathway seems to be unaffected in primary patient cells (Figure 1) [63]. This data support 
the idea that different proteolytic branches of the cytoplasmic UPS might hold different sensitivity 
towards mitochondrial oxidative stress. Alternatively, the UPS might reinforce activity and/or 
localization of the 26S proteasome especially under metabolic stress conditions, to ensure optimal 
quality control of the organelle when the proteolytic capacity of the cytoplasm is limited. In support 
of this idea, imbalances in mitochondrial protein import from the cytosol activates a cellular 
response supporting proteostasis through decreased de-novo protein synthesis and elevated 
proteasomal activity, due to enhanced proteasome assembly [65]. Increased ROS production 
caused by mitochondrial inhibition can also block the 26S proteasome through oxidation-induced 
disassembly into 20S core and 19S regulatory particles. The reversible nature of the proteasomal 
assembly state suggests an adaptive response mechanism triggered by cellular stress [64], [65]. 
It is therefore intriguing to speculate that decreased UPS activity potentiates development and 
progression of metabolic diseases through a conserved mitochondrial surveillance response.  
  
Role of mitochondrial homeostasis in organismal development and health  
Mitochondria are key organelles for viability of eukaryotic cells. Consequently, functional decline 
of mitochondria has direct implications in human pathophysiology. Above altered cellular 
bioenergetics, mitochondria dysfunction also produces damaging agents and initiate cellular 
pathways, such as stress responses, proteolysis or cell death, which ultimately modify cellular 
homeostasis and cellular fate. Muscles and neuronal cells represent the most energydemanding 
tissues in the human body. Although mitochondria are present and essential for almost all cell 
types, the majority of human diseases associated with altered mitochondrial function, primarily 
affect the neuronal system, cardiac and skeletal muscle tissues (Table 2). Mitochondrial defects 
associated with elevated levels of oxidative stress have been linked to ageing and 
neurodegenerative diseases, such as AD, HD, and PD [66], [67]. Interestingly, the ubiquitin variant 
UBB+1 accumulates in brain tissues of AD patients, causing neuronal death [68]. Ectopic UBB+1 
expression in yeast causes oxidative stress, fragmentation of the mitochondrial network as well 
as apoptosis. Importantly, increased expression of Cdc48/p97 or Vms1 alleviates the cytotoxic 
effects of UBB+1 [33]. Cdc48/p97 enhances the degradation of the toxic ubiquitin variant, while 
Vms1 expression reduces toxic effects on the mitochondria by a process involved in regulation of 
basic amino acid synthesis. UBB+1 co-exists with Vms1 in hippocampal neurons of AD patients, 
suggesting that MAD pathway components are crucial in fighting disease progression [33]. 
Similarly, overexpression of the proteasomal subunit RPN6, a stabilizing factor of the full 26S 
proteasome [69], has also been shown to surpass mitochondrial inhibition of cellular proteolysis 
at the proteasome [63]. These observations suggest that mitochondrial damage-induced cellular 
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dysfunction can be efficiently counteracted by enhanced activation of the ubiquitin-mediated 
protein turnover, offering alternative target specificity in the treatment of mitochondria-linked 
diseases.  
Besides the role of impaired mitochondrial functionality in human pathologies, mitochondrial 
integrity has far reaching implications on organismal development, health, and ageing.  
Accordingly, the cellular content as well as dynamic morphology of mitochondria are carefully 
balanced by regulated biogenesis and mitophagy during both organismal ageing and in response 
to stress conditions [70]. Mild mitochondrial dysfunction triggers adaptive mechanisms including 
the UPRmit, enhancing cellular health, and organismal fitness [71]. Interestingly, mitochondrial 
dysfunction in a defined tissue is capable of initiating this systemic response in distal tissues in C. 
elegans and Drosophila [72], [73]. In this regard, it is intriguing that sensing of energy status 
specifically in neurons coordinates mitochondrial morphology in distinct tissues [74]. Thus, the 
central nervous system likely acts as the topmost regulator of mitochondrial function in 
multicellular organisms, which is capable of overwriting systemic responses from other tissues 
[74]. The role of ubiquitin-mediated protein degradation in surveillance of mitochondrial function 
is evident, however, the connection to regulating systemic health and ageing remains elusive.  
  
Concluding remarks  
In contrast to cellular mechanisms ensuring mitochondrial functionality, our knowledge on the co-
existence and crosstalk between distinct surveillance pathways is largely fragmentary. 
PINK1/Parkin promote mitochondrial fission through selective proteasomal degradation of 
mitofusins [36]. Conversely, more than 100 substrates are potentially ubiquitylated upon 
depolarization to trigger mitophagy [34], [46]. The signals that decide between degradation of 
mitochondrial proteins or the entire organelle are not known yet. It is intriguing to speculate that 
the amount and/or topology of ubiquitin chains attached to mitochondria might coordinate 
proteasomal targeting and autophagy via selective recruitment of specific ubiquitin receptors. 
Alternatively, MAD and mitophagy are probably activated through separated signaling cascades. 
Accordingly, phosphorylated ubiquitin has recently been suggested to serve as the decisive signal 
that initiates mitophagy through direct recruitment of selective autophagy receptors [75]. The 
cooperation with intrinsic mitochondrial proteostasis pathways as well as the integration of MAD 
and mitophagy into the UPRmit demands further investigation [27], [28], [76]– [78]. Moreover, it is 
also important to uncover the signaling pathway that either activate or attenuate cytosolic 
proteasome activity upon mitochondrial dysfunction. Mechanistic insights into mitochondrial 
surveillance and the crosstalk between underlying signaling pathways will help to understand 
disease pathology and provide therapeutic strategies.  
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Figure Legends, Table Legends, Content of boxes  
Figure1  
Control of mitochondrial dynamics and removal of dysfunctional mitochondria by 
cytosolic protein degradation   
(a) Mitochondrial fission and fusion events shape the morphology of the mitochondrial 
network in eukaryotic cells. Ubiquitylation and deubiquitylation of critical regulator proteins is 
decisive of initiating mitochondrial fission (red) or fusion (blue), respectively. Several substrates 
have been shown to be degraded by the 26S proteasome upon ubiquitylation. However, 
alternative pathways are also described involving ubiquitin-dependent oligomerization and 
protein-protein interaction. Regulation of mitochondrial morphology is vital for cellular health and 
survival and can also be modulated upon physiological adaption, such as cell division or 
differentiation. See text and Table1 for further details.  
(b) Mitochondrial functionality can be threatened from intrinsic or extrinsic sources. Damaged 
proteins from inside and outside surfaces of mitochondria are degraded in a pathway relying on 
the cytosolic UPS, called the mitochondria-associated protein degradation (MAD). The precise 
recognition and translocation pathways of proteins from the Matrix, IMM, and IMS remain to be 
elucidated. Substrate proteins associated with the OMM require membrane dislocation by the 
ubiquitin-dependent segregase Cdc48/p97, enabling subsequent degradation by the proteasome. 
In turn, generation of reactive oxygen species (ROS) upon mitochondrial dysfunction can result 
of reduced proteasomal activity in the cytosol (UFD, and N-end rule substrates). Severely 
damaged mitochondria are removed by autophagic degradation (mitophagy). Herein, 
ubiquitylation of proteins in the OMM is recognized by dedicated adaptor proteins (autophagy 
receptors) that recruit the phagophore through interaction with ubiquitin and LC3, respectively. 
Completing maturation, an autophagosomal double-membrane engulfs mitochondria. 
Subsequent, fusion with the lysosome triggers the degradation of biomolecules.  
See text and Table 1 for further information.  
  
Table 1  
UPS components regulating mitochondrial dynamics, mitochondria-associated 
degradation (MAD), and mitophagy  
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The table summarizes components of the UPS that are implicated in the regulation of 
mitochondrial dynamics, the MAD pathway, or mitophagy. Experimental systems and specific 
substrate proteins are displayed wherever applicable.  
  
Table 2  
Human pathologies linked to defects in mitochondrial protein quality control  
The table summarizes human pathologies that are linked to defects in mitochondrial morphology 
or protein quality control.  
  
Box1   
Ubiquitin-mediated proteolysis by the UPS and autophagy  
Targeted protein degradation is fundamental for cellular function and viability. Selected protein 
turnover is a fast and powerful regulatory mechanism to inactivate signaling proteins or cellular 
determinants, e.g. to drive cell cycle progression or development. In addition, protein degradation 
is vital for the removal of non-functional or aberrant proteins to prevent cytotoxicity. Both major 
protein degradation pathways in eukaryotic cells, the ubiquitin-proteasome system (UPS) and 
autophagy, involve posttranslational modification of target proteins with ubiquitin. Ubiquitylation of 
substrates is catalyzed by an enzymatic cascade of ubiquitin-activating (E1), ubiquitin-conjugating 
(E2), and ubiquitin-ligating (E3) enzymes. Following ubiquitin conjugation to a substrate protein, 
ubiquitin-chains are formed by iterative linkage of one ubiquitin molecule to the other. 
Deubiquitylation by ubiquitin-hydrolases or DUBs serves as an important regulatory mechanism 
of chain length or topology. Ubiquitin-receptors bind to ubiquitin-chains assembled on target 
proteins and initiate their transfer and terminal degradation by the 26S proteasome. Alternatively, 
in a process that has been termed selective autophagy, ubiquitin-receptors can bridge to 
autophagic protein degradation by recognition of membrane-conjugated LC3 family protein (a 
ubiquitin-like molecule). LC3 is conjugated to the forming phagophore, a doublelayered 
membrane that eventually engulfs the ubiquitylated material, which can be aggregated proteins, 
entire organelles, or pathogenic bacteria. After maturation into an autophagic vesicle, fusion with 
the lysosome enables the degradation of biomolecules, including proteins, by lysosomal 
hydrolases. Interestingly, recent observations strongly suggest that both pathways, the UPS and 
autophagy, are tightly interconnected. First, loss of one degradation pathway can partially be 
compensated by the other, implicating functional redundancy. Moreover, the signaling promoting 
autophagosomal degradation underlies control by the UPS. In turn, proteasomes can be degraded 
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via autophagy. Thus, it appears very likely that intricate crosscommunication between both 
ubiquitin-mediated protein degradation pathways exist, waiting to be deciphered.  
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Table 1 
UPS components governing mitochondrial dynamics, mitochondria-associated degradation (MAD) and mitophagy 
Mitochondria fission and  
UPS component Organism / system Substrate Reference fusion 
E3 MAPL (Mulan, Mul1) mammalian cells Drp1 Braschi et al. 2009 
 mammalian cells and Drosophila Mfn,Mfn1, Mfn2 Yun et al., 2014 
March5 (MITOL) mammalian cells Mfn2, Drp1 Nakamura et al. 2006 Mfn1 Park and Cho, 2012 
 Drp1 Karbowski et al. 2007 
 Mfn2 Sugiura et al. 2013 
 Fis1 Yonashiro et al., 2006 
Fang et al. 2013 
 Parkin mammalian cells Mfn1 Glauser et al. 2011 
 Mfn1, Mfn2 Gegg et al. 2010 
 Huwe1/Mule mammalian cells Mfn2 Leboucher et al., 2012 
 APC/C Cdh1 complex mammalian cells Drp1 Horn et al. 2011 
 RNF5 mammalian cells Fis1 Zhang et al. 2012 
DUB Ubp16 yeast Kinner and Koelling 2003 
 UBP27 Arabidopsis DRP3 Pan et al. 2014 
 USP30 mammalian cells Mfn1, Mfn2 Yue et al. 2014 
Nakamura and Hirose et al. 2007 
 Ubp2 and Ubp12 yeast Fzo1 Anton et al. 2012 
F-box protein Fbxl7 mammalian cells Survivin Liu et al. 2015 
 Mfb1 yeast Duerr et al. 2006 
Kondo-Okamoto et al. 2006 
 Mdm30 yeast Fzo1 Fritz et al. 2003 
 Fzo1 Escobar-Henriques et al. 2006 
 Fzo1 Cohen et al. 2008 
 Fzo1 Cohen et al. 2011 
Duerr et al. 2006 
MAD UPS component Organism / system Substrate Reference 
 E3 Parkin mammalian cells Mfn1 Mcl1 Xu et al. 2010 
 Mfn1 Mfn2 Tanaka t al. 2010 
 variety of substrates Sarraf et al. 2013 
 Mfn1 Glauser et al. 2011 
 Mfn1, Mfn2 Gegg et al. 2010 
 Drosophila respiratory chain  Vincow et al. 2013 
components 
 Mulan Mitofusins Tyun et al. 2013 
AAA family  ATPase Cdc48/p97 mammalian cells Mfn1 Mfn2 Tanaka t al. 2010 
 Mfn1 Mcl1 Xu et al. 2010 
Hemion et al. 2014 
Fang et al. 2015 mammalian cells and Drosophila Kim et al. 2013 
Cdc48 cofactor Vms1 yeast and C. elegans Heo et al. 2010  
Mitophagy UPS component Organism / system Substrate Reference 
E2 UBE2A mammalian cells and Drosophila Parkin substrates Haddad et al., 2013 
 UBE2N, UBE2D2,  mammalian cells Parkin substrates Geisler et al., 2014 
UBE2D3, UBE2L3 
 UBE2N, UBE2D2,  mammalian cells Parkin substrates Fiesel et al., 2014 
UBE2D3, UBE2L3 
 UBE2R1/CDC34 mammalian cells Fiesel et al., 2014 
 Ube2E3 mammalian cells Mulan targets Ambivero et al., 2014 
E3 Parkin mammalian cells Mff Gao et al. 2015 
 VDAC1 Geisler et al., 2010 
mammalian cells and Drosophila Miro Wanget al. 2011 Miro Liu et al. 
2012 
C. elegans Palikaras et el. 2015 Gp78 mammalian cells Mfn1, Mfn2 Fu et al. 2013 
 Mulan mammalian cells Mfn2 Lokireddy et al. 2012 
 GABARAB Ambivero et al., 2014 
 Mul1 mammalian cells Ulk1 Li et al., 2015 
 RNF185 mammalian cells BNIP1 Tang et al. 2011 
DUB USP8 mammalian cells Parkin Durcan et al., 2014 
 USP15 mammalian cells and Drosophila Cornelissen et al. 2014 
 USP30 mammalian cells Parkin substrates Bingol et al., 2014;  
 USP35 mammalian cells Wang et al., 2015 
 Table 
Table 2 
Human pathologies linked to factors involved in mitochondrial protein quality control 
UPS Disease Reference 
Parkin Parkinson's disease (PD) Kitada et al., 1998; Lücking et al., 2000 
Huwe1/Mule nonsyndromic intellectual disability (ID) Froyen et al., 2008 
Cdc48/p97 amyotrophic lateral sclerosis (ALS); Inclusion body myopathy Johnson et al., 2010; Watts et al., 2004 with early-onset Paget 
disease and frontotemporal dementia (IBMPFD) 
Fission-fusion Disease Reference 
OPA1 Autosomal Dominant Optic Atrophy 1 (ADOA) Delettre et al., 2000; Alexander et al., 2000 
Mfn2 Charcot–Marie–Tooth syndrome type 2A (CMT2A) Züchner etal., 2004 
OPA3 3-methylglutaconic aciduria 3 (MGA3 or Costeff optic atrophy Anikster etal., 2001; Reynier et al., 2004 syndrome); Optic atrophy 3 (OPA3) 
DRP1 Lethal encephalopathy due to mitochondrial and peroxisomal Waterham et al., 2007 
fission defect 
GDAP1 Charcot–Marie–Tooth syndrome type 4A (CMT4A);  Baxter etal., 2002; Sahin-Calapoglu et al., 2009 
Charcot–Marie–Tooth syndrome type 2K CMT2K 
Mitophagy Disease Reference 
Parkin Parkinson's disease (PD) Kitada et al., 1998; Lücking et al., 2000 
PINK1 Parkinson's disease (PD) Valente et al., 2004 
UBE2A X-linked intellectual disability (XLID) Nascimento et al., 2006 
USP8 Cushing's disease Reincke et al., 2015; Ma et al.,2015 
LAMP2 Danon disease Arad etal., 2005 
p62 Paget disease of bone (PDB) Laurin et al., 2002; Hocking et al., 2002 
optineurin amyotrophic lateral sclerosis (ALS); Primary open-angle  Maruyama et al., 2010; Rezaie et al., 2002 
glaucoma (POAG) 
 
